Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)

ClinicalTrials.gov ID: NCT04042844

Public ClinicalTrials.gov record NCT04042844. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 5:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-Blind, Controlled, Randomized Study to Evaluate the Safety and Preliminary Efficacy of a Single Dose Intradiscal Injection of BRTX-100 for Patients With Chronic Lumbar Disc Disease (cLDD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a double-blind, controlled, randomized study with blinded assessments using a single dose. Subjects that have a current diagnosis of chronic lumbar disc disease and meet eligibility criteria will be enrolled. Chronic lumbar disc disease is defined as back and/or radicular pain with degeneration of the disc confirmed by patient history, physical examination, and radiographic measures such as computed tomography (CT), magnetic resonance imaging (MRI), plain film, myelography, discography, or other acceptable means.

Study identification

NCT ID
NCT04042844
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
BioRestorative Therapies
Industry
Enrollment
99 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 29, 2022
Primary completion
Nov 30, 2026
Completion
Nov 30, 2027
Last update posted
Aug 25, 2025

2022 – 2027

United States locations

U.S. sites
19
U.S. states
11
U.S. cities
18
Facility City State ZIP Site status
Alabama Clinical Therapeutics, LLC Birmingham Alabama 35235 Withdrawn
Source Healthcare Santa Monica California 90403 Recruiting
Boomerang Healthcare Walnut Creek California 94598 Recruiting
Denver Back Pain Specialists, LLC Greenwood Village Colorado 80111 Recruiting
Cantor Spine Institute Fort Lauderdale Florida 33306 Withdrawn
Coastal Health Jacksonville Florida 32257 Recruiting
Pain Relief Centers St. Petersburg Florida 33709 Recruiting
Tampa Pain Relief Center Tampa Florida 33603 Recruiting
Florida Pain Relief Center Tampa Florida 33614 Recruiting
Conquest Research Winter Park Florida 32789 Recruiting
Northwell Health New York New York 10022 Recruiting
The Center of Clinical Research, LLC Winston-Salem North Carolina 27103 Recruiting
Cleveland Clinic Cleveland Ohio 44195 Recruiting
Clinical Investigations LLC Edmond Oklahoma 73013 Withdrawn
Coastal Carolina Research Center North Charleston South Carolina 29406, Withdrawn
Science Connections Austin Texas 78758 Recruiting
NCP Center for Clinical Research and Innovation Houston Texas 77008 Recruiting
Precision Spine Care Tyler Texas 75701 Withdrawn
Virginia iSpine Physicians Richmond Virginia 23235 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04042844, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 25, 2025 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04042844 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →